Filament Health Statistics

Total Valuation

Filament Health has a market cap or net worth of CAD 35,763. The enterprise value is 208,563.

Market Cap	35,763
Enterprise Value	208,563

Important Dates

The last earnings date was Tuesday, April 14, 2026.

Earnings Date	Apr 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	261.79M
Shares Outstanding	n/a
Shares Change (YoY)	+14.60%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	37.99%
Owned by Institutions (%)	n/a
Float	111.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.08
PB Ratio	0.07
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.05
EV / Sales	0.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.16

Financial Position

The company has a current ratio of 0.30, with a Debt / Equity ratio of 0.98.

Current Ratio	0.30
Quick Ratio	0.30
Debt / Equity	0.98
Debt / EBITDA	n/a
Debt / FCF	-0.38
Interest Coverage	-17.48

Financial Efficiency

Return on equity (ROE) is -272.16% and return on invested capital (ROIC) is -96.18%.

Return on Equity (ROE)	-272.16%
Return on Assets (ROA)	-54.69%
Return on Invested Capital (ROIC)	-96.18%
Return on Capital Employed (ROCE)	-274.11%
Weighted Average Cost of Capital (WACC)	24.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	n/a

Taxes

Income Tax	-12,173
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.82% in the last 52 weeks. The beta is 0.91, so Filament Health's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-81.82%
50-Day Moving Average	0.02
200-Day Moving Average	0.03
Relative Strength Index (RSI)	38.54
Average Volume (20 Days)	212,706

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.80

Income Statement

In the last 12 months, Filament Health had revenue of CAD 458,539 and -4.11 million in losses. Loss per share was -0.02.

Revenue	458,539
Gross Profit	458,539
Operating Income	-2.95M
Pretax Income	-4.12M
Net Income	-4.11M
EBITDA	-2.97M
EBIT	-2.95M
Loss Per Share	-0.02

Balance Sheet

The company has 337,082 in cash and 513,266 in debt, giving a net cash position of -176,184.

Cash & Cash Equivalents	337,082
Total Debt	513,266
Net Cash	-176,184
Net Cash Per Share	n/a
Equity (Book Value)	525,306
Book Value Per Share	0.00
Working Capital	-1.23M

Cash Flow

In the last 12 months, operating cash flow was -1.34 million and capital expenditures -2,733, giving a free cash flow of -1.34 million.

Operating Cash Flow	-1.34M
Capital Expenditures	-2,733
Depreciation & Amortization	-23,419
Net Borrowing	803,093
Free Cash Flow	-1.34M
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-643.17%
Pretax Margin	-898.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Filament Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.60%
Shareholder Yield	-14.60%
Earnings Yield	-11,480.26%
FCF Yield	-3,760.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Filament Health has an Altman Z-Score of -20.04 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.04
Piotroski F-Score	1